Education
About Us
Working with TipRanks
Follow Us
Quantum Biopharma (QNTM)
NASDAQ:QNTM
Total Valuation
Quantum Biopharma has a market cap or net worth of $18.44M. The enterprise value is ―.
Market Cap$18.44M
Enterprise Value―
Share Statistics
Quantum Biopharma has 2,299,748 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,299,748
Owned by Insiders37.92%
Owned by Institutions2.70%
Financial Efficiency
Quantum Biopharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count9
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Quantum Biopharma is ―. Quantum Biopharma’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Quantum Biopharma had revenue of ― and earned -17.90M in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income-19.23M
Pretax Income―
Net Income-17.90M
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Quantum Biopharma pays an annual dividend of $0.419, resulting in a dividend yield of ―
Dividend Per Share$0.419
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-50.58%
50-Day Moving Average6.90
200-Day Moving Average5.48
Relative Strength Index (RSI)62.27
Average Volume (3m)116.97K
Important Dates
Quantum Biopharma upcoming earnings date is Nov 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend DateNov 27, 2023
Financial Position
Quantum Biopharma as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Quantum Biopharma has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Quantum Biopharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Quantum Biopharma has ― in cash and marketable securities with 339.20K in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt339.20K
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Quantum Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―